Global Crohn’s Disease Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Crohn’s Disease Therapeutics Market Size 2017-2028

2.1.2 Crohn’s Disease Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Crohn’s Disease Therapeutics Segment by Type

2.2.1 Non-Surgical

2.2.2 Surgical

2.3 Crohn’s Disease Therapeutics Market Size by Type

2.3.1 Crohn’s Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Crohn’s Disease Therapeutics Segment by Application

2.4.1 Hospitals

2.4.2 Ambulatory Surgical Centers

2.5 Crohn’s Disease Therapeutics Market Size by Application

2.5.1 Crohn’s Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

3 Crohn’s Disease Therapeutics Market Size by Player

3.1 Crohn’s Disease Therapeutics Market Size Market Share by Players

3.1.1 Global Crohn’s Disease Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Crohn’s Disease Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Crohn’s Disease Therapeutics by Regions

4.1 Crohn’s Disease Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Crohn’s Disease Therapeutics Market Size Growth (2017-2022)

4.3 APAC Crohn’s Disease Therapeutics Market Size Growth (2017-2022)

4.4 Europe Crohn’s Disease Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Crohn’s Disease Therapeutics Market Size by Country (2017-2022)

5.2 Americas Crohn’s Disease Therapeutics Market Size by Type (2017-2022)

5.3 Americas Crohn’s Disease Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Crohn’s Disease Therapeutics Market Size by Region (2017-2022)

6.2 APAC Crohn’s Disease Therapeutics Market Size by Type (2017-2022)

6.3 APAC Crohn’s Disease Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Crohn’s Disease Therapeutics by Country (2017-2022)

7.2 Europe Crohn’s Disease Therapeutics Market Size by Type (2017-2022)

7.3 Europe Crohn’s Disease Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Crohn’s Disease Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Crohn’s Disease Therapeutics Market Forecast

10.1 Global Crohn’s Disease Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Crohn’s Disease Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Crohn’s Disease Therapeutics Forecast

10.1.3 APAC Crohn’s Disease Therapeutics Forecast

10.1.4 Europe Crohn’s Disease Therapeutics Forecast

10.1.5 Middle East & Africa Crohn’s Disease Therapeutics Forecast

10.2 Americas Crohn’s Disease Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Crohn’s Disease Therapeutics Market Forecast

10.2.2 Canada Crohn’s Disease Therapeutics Market Forecast

10.2.3 Mexico Crohn’s Disease Therapeutics Market Forecast

10.2.4 Brazil Crohn’s Disease Therapeutics Market Forecast

10.3 APAC Crohn’s Disease Therapeutics Forecast by Region (2023-2028)

10.3.1 China Crohn’s Disease Therapeutics Market Forecast

10.3.2 Japan Crohn’s Disease Therapeutics Market Forecast

10.3.3 Korea Crohn’s Disease Therapeutics Market Forecast

10.3.4 Southeast Asia Crohn’s Disease Therapeutics Market Forecast

10.3.5 India Crohn’s Disease Therapeutics Market Forecast

10.3.6 Australia Crohn’s Disease Therapeutics Market Forecast

10.4 Europe Crohn’s Disease Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Crohn’s Disease Therapeutics Market Forecast

10.4.2 France Crohn’s Disease Therapeutics Market Forecast

10.4.3 UK Crohn’s Disease Therapeutics Market Forecast

10.4.4 Italy Crohn’s Disease Therapeutics Market Forecast

10.4.5 Russia Crohn’s Disease Therapeutics Market Forecast

10.5 Middle East & Africa Crohn’s Disease Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Crohn’s Disease Therapeutics Market Forecast

10.5.2 South Africa Crohn’s Disease Therapeutics Market Forecast

10.5.3 Israel Crohn’s Disease Therapeutics Market Forecast

10.5.4 Turkey Crohn’s Disease Therapeutics Market Forecast

10.5.5 GCC Countries Crohn’s Disease Therapeutics Market Forecast

10.6 Global Crohn’s Disease Therapeutics Forecast by Type (2023-2028)

10.7 Global Crohn’s Disease Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Johnson and Johnson Services Inc.

11.1.1 Johnson and Johnson Services Inc. Company Information

11.1.2 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Offered

11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Johnson and Johnson Services Inc. Main Business Overview

11.1.5 Johnson and Johnson Services Inc. Latest Developments

11.2 Pfizer Inc.

11.2.1 Pfizer Inc. Company Information

11.2.2 Pfizer Inc. Crohn’s Disease Therapeutics Product Offered

11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Pfizer Inc. Main Business Overview

11.2.5 Pfizer Inc. Latest Developments

11.3 Allergan

11.3.1 Allergan Company Information

11.3.2 Allergan Crohn’s Disease Therapeutics Product Offered

11.3.3 Allergan Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Allergan Main Business Overview

11.3.5 Allergan Latest Developments

11.4 AbbVie Inc.

11.4.1 AbbVie Inc. Company Information

11.4.2 AbbVie Inc. Crohn’s Disease Therapeutics Product Offered

11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AbbVie Inc. Main Business Overview

11.4.5 AbbVie Inc. Latest Developments

11.5 Takeda Pharmaceutical Company Limited

11.5.1 Takeda Pharmaceutical Company Limited Company Information

11.5.2 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Offered

11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Takeda Pharmaceutical Company Limited Main Business Overview

11.5.5 Takeda Pharmaceutical Company Limited Latest Developments

11.6 Celgene Corporation

11.6.1 Celgene Corporation Company Information

11.6.2 Celgene Corporation Crohn’s Disease Therapeutics Product Offered

11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Celgene Corporation Main Business Overview

11.6.5 Celgene Corporation Latest Developments

11.7 Perrigo Company PLC

11.7.1 Perrigo Company PLC Company Information

11.7.2 Perrigo Company PLC Crohn’s Disease Therapeutics Product Offered

11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Perrigo Company PLC Main Business Overview

11.7.5 Perrigo Company PLC Latest Developments

11.8 Ferring B.V.

11.8.1 Ferring B.V. Company Information

11.8.2 Ferring B.V. Crohn’s Disease Therapeutics Product Offered

11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Ferring B.V. Main Business Overview

11.8.5 Ferring B.V. Latest Developments

11.9 Salix Pharmaceuticals

11.9.1 Salix Pharmaceuticals Company Information

11.9.2 Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Offered

11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Salix Pharmaceuticals Main Business Overview

11.9.5 Salix Pharmaceuticals Latest Developments

11.10 Gilead Sciences Inc.

11.10.1 Gilead Sciences Inc. Company Information

11.10.2 Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Offered

11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Gilead Sciences Inc. Main Business Overview

11.10.5 Gilead Sciences Inc. Latest Developments

11.11 Genentech Inc.

11.11.1 Genentech Inc. Company Information

11.11.2 Genentech Inc. Crohn’s Disease Therapeutics Product Offered

11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Genentech Inc. Main Business Overview

11.11.5 Genentech Inc. Latest Developments

11.12 UCB India Private Limited.

11.12.1 UCB India Private Limited. Company Information

11.12.2 UCB India Private Limited. Crohn’s Disease Therapeutics Product Offered

11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 UCB India Private Limited. Main Business Overview

11.12.5 UCB India Private Limited. Latest Developments

12 Research Findings and Conclusion

Table 1. Crohn’s Disease Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Non-Surgical

Table 3. Major Players of Surgical

Table 4. Crohn’s Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 7. Crohn’s Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 10. Global Crohn’s Disease Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Crohn’s Disease Therapeutics Revenue Market Share by Player (2020-2022)

Table 12. Crohn’s Disease Therapeutics Key Players Head office and Products Offered

Table 13. Crohn’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Crohn’s Disease Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Crohn’s Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Table 18. Americas Crohn’s Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Crohn’s Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 20. Americas Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 22. Americas Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 24. APAC Crohn’s Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Crohn’s Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 26. APAC Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 28. APAC Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 30. Europe Crohn’s Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Crohn’s Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 32. Europe Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 34. Europe Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Crohn’s Disease Therapeutics

Table 43. Key Market Challenges & Risks of Crohn’s Disease Therapeutics

Table 44. Key Industry Trends of Crohn’s Disease Therapeutics

Table 45. Global Crohn’s Disease Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Crohn’s Disease Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Crohn’s Disease Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Crohn’s Disease Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 51. Johnson and Johnson Services Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 52. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product Offered

Table 53. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Johnson and Johnson Services Inc. Main Business

Table 55. Johnson and Johnson Services Inc. Latest Developments

Table 56. Pfizer Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 57. Pfizer Inc. Crohn’s Disease Therapeutics Product Offered

Table 58. Pfizer Inc. Main Business

Table 59. Pfizer Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Pfizer Inc. Latest Developments

Table 61. Allergan Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 62. Allergan Crohn’s Disease Therapeutics Product Offered

Table 63. Allergan Main Business

Table 64. Allergan Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Allergan Latest Developments

Table 66. AbbVie Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 67. AbbVie Inc. Crohn’s Disease Therapeutics Product Offered

Table 68. AbbVie Inc. Main Business

Table 69. AbbVie Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. AbbVie Inc. Latest Developments

Table 71. Takeda Pharmaceutical Company Limited Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 72. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product Offered

Table 73. Takeda Pharmaceutical Company Limited Main Business

Table 74. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Takeda Pharmaceutical Company Limited Latest Developments

Table 76. Celgene Corporation Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 77. Celgene Corporation Crohn’s Disease Therapeutics Product Offered

Table 78. Celgene Corporation Main Business

Table 79. Celgene Corporation Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Celgene Corporation Latest Developments

Table 81. Perrigo Company PLC Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 82. Perrigo Company PLC Crohn’s Disease Therapeutics Product Offered

Table 83. Perrigo Company PLC Main Business

Table 84. Perrigo Company PLC Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Perrigo Company PLC Latest Developments

Table 86. Ferring B.V. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 87. Ferring B.V. Crohn’s Disease Therapeutics Product Offered

Table 88. Ferring B.V. Main Business

Table 89. Ferring B.V. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Ferring B.V. Latest Developments

Table 91. Salix Pharmaceuticals Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 92. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product Offered

Table 93. Salix Pharmaceuticals Main Business

Table 94. Salix Pharmaceuticals Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Salix Pharmaceuticals Latest Developments

Table 96. Gilead Sciences Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 97. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product Offered

Table 98. Gilead Sciences Inc. Main Business

Table 99. Gilead Sciences Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Gilead Sciences Inc. Latest Developments

Table 101. Genentech Inc. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 102. Genentech Inc. Crohn’s Disease Therapeutics Product Offered

Table 103. Genentech Inc. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Genentech Inc. Main Business

Table 105. Genentech Inc. Latest Developments

Table 106. UCB India Private Limited. Details, Company Type, Crohn’s Disease Therapeutics Area Served and Its Competitors

Table 107. UCB India Private Limited. Crohn’s Disease Therapeutics Product Offered

Table 108. UCB India Private Limited. Main Business

Table 109. UCB India Private Limited. Crohn’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. UCB India Private Limited. Latest Developments

List of Figures

Figure 1. Crohn’s Disease Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Crohn’s Disease Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Crohn’s Disease Therapeutics Market Size Market Share by Type in 2021

Figure 7. Crohn’s Disease Therapeutics in Hospitals

Figure 8. Global Crohn’s Disease Therapeutics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Crohn’s Disease Therapeutics in Ambulatory Surgical Centers

Figure 10. Global Crohn’s Disease Therapeutics Market: Ambulatory Surgical Centers (2017-2022) & ($ Millions)

Figure 11. Global Crohn’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 12. Global Crohn’s Disease Therapeutics Revenue Market Share by Player in 2021

Figure 13. Global Crohn’s Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Crohn’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 15. APAC Crohn’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 16. Europe Crohn’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Crohn’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Americas Crohn’s Disease Therapeutics Value Market Share by Country in 2021

Figure 19. Americas Crohn’s Disease Therapeutics Consumption Market Share by Type in 2021

Figure 20. Americas Crohn’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 21. United States Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Crohn’s Disease Therapeutics Market Size Market Share by Region in 2021

Figure 26. APAC Crohn’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 27. China Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Crohn’s Disease Therapeutics Market Size Market Share by Country in 2021

Figure 34. Europe Crohn’s Disease Therapeutics Market Size Market Share by Type in 2021

Figure 35. Europe Crohn’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 36. Germany Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 44. Egypt Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Crohn’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 50. APAC Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 51. Europe Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. United States Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Canada Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. China Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Japan Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Korea Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. India Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Australia Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Germany Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. France Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. UK Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Italy Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Russia Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Spain Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Israel Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Crohn’s Disease Therapeutics Market Size 2023-2028 ($ Millions)